| NDC Code | 68084-416-25 |
|---|
| Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-416-25) > 1 TABLET, FILM COATED in 1 BLISTER PACK (68084-416-95) |
|---|
| Product NDC | 68084-416 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Lamivudine And Zidovudine |
|---|
| Non-Proprietary Name | Lamivudine And Zidovudine |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140215 |
|---|
| End Marketing Date | 20221231 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA202418 |
|---|
| Manufacturer | American Health Packaging |
|---|
| Substance Name | LAMIVUDINE; ZIDOVUDINE |
|---|
| Strength | 150; 300 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA] |
|---|